Neurology
0 drugs are in development for Gait Disorders, Neurologic.
- Companies
- 0
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Gait Disorders, Neurologic pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Gait Disorders, Neurologic context
Neurology·MeSH: Gait Disorders, Neurologic (D020233)
Also known as: Ambulation Disorder, Neurologic, Ambulation Disorders, Neurologic, Gait Disorder, Neurologic, Gait Dysfunctions, Neurologic, Locomotion Disorder, Neurologic, Locomotion Disorders, Neurologic, Neurologic Gait Dysfunction
Prevalence
38224.7 / 100K
Incidence
10843.7 / 100K/yr
Frequently asked questions
How many clinical trials target Gait Disorders, Neurologic?
There are 6 clinical trials targeting Gait Disorders, Neurologic tracked by BioSniper.
What is the prevalence of Gait Disorders, Neurologic?
The estimated prevalence of Gait Disorders, Neurologic is approximately 38224.7 per 100,000 population.